Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KRYS

Krystal Biotech Inc

May 29 • 12:42PM ET

310.36

+0.06 0.02 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM IONS ALNY INCY MDGL NUVL VKTX UTHR PCRX

| Held by: IJR VTI IWM VB XBI FBT VBK VXF SPSM IJT

Scroll to Statements

Index	RUT	P/E	41.48	EPS (ttm)	7.48	Insider Own	12.75%	Shs Outstand	29.44M	Perf Week	2.01%
Market Cap	9.15B	Forward P/E	31.96	EPS next Y	9.71	Insider Trans	-6.35%	Shs Float	25.72M	Perf Month	19.39%
Enterprise Value	8.33B	PEG	1.38	EPS next Q	1.79	Inst Own	96.11%	Short Float	12.38%	Perf Quarter	12.59%
Income	225.03M	P/S	21.92	EPS this Y	13.33%	Inst Trans	-0.76%	Short Ratio	11.42	Perf Half Y	43.04%
Sales	417.30M	P/B	7.16	EPS next Y	25.28%	ROA	18.21%	Short Interest	3.18M	Perf YTD	25.88%
Book/sh	43.37	P/C	11.11	EPS next 5Y	23.11%	ROE	19.90%	52W High	319.48 -2.86%	Perf Year	147.08%
Cash/sh	27.93	P/FCF	38.54	EPS past 3/5Y	- -	ROIC	17.53%	52W Low	123.03 152.25%	Perf 3Y	157.60%
Dividend Est.	-	EV/EBITDA	44.99	Sales past 3/5Y	- -	Gross Margin	92.72%	Volatility	3.08% 4.25%	Perf 5Y	375.71%
Dividend TTM	-	EV/Sales	19.97	EPS Y/Y TTM	79.56%	Oper. Margin	42.81%	ATR (14)	10.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.06	Sales Y/Y TTM	25.15%	Profit Margin	53.92%	RSI (14)	62.60	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	9.46	EPS Q/Q	53.27%	SMA20	3.31%	Beta	0.53	Target Price	330.56
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	31.95%	SMA50	11.85%	Rel Volume	0.59	Prev Close	310.30
Employees	295	LT Debt/Eq	0.01	Earnings	May 04 BMO	SMA200	33.47%	Avg Volume	278.73K	Price	310.36
IPO	Sep 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.80% 3.79%	Trades		Volume	85,274	Change	0.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)